With the impending retirement later this month of ASAP president and CEO Michael Leonetti, CSAP, “a key feature of our alliance community” is moving on, ushering in a new era for ASAP. That was the description given by Brooke Paige, CSAP, digital alliance leader at Novartis, as she... Continue Reading
Change is a constant in biopharma partnering, and a panel of alliance leaders examined the skills and capabilities needed to confront the ongoing challenges on opening day of the 2023 ASAP BioPharma Conference in Boston. Continue Reading
Day 2 of the 2023 ASAP BioPharma Conference kicked off with a panel exploring the world of drug development technology platform alliances—multiple programs, therapeutic areas, and indications. IP protection, stakeholder management, and surprises, big and small, put alliance managers to the test. Continue Reading
Empathy helps helps drive powerful outcomes for patients and consumers—and great business outcomes! So said Doug Wenners during his ASAP BioPharma Conference keynote presentation. Continue Reading
Day One of the 2023 ASAP BioPharma Conference is here! And the Leadership Forum looked at the emerging role of the alliance operations manager along with all that goes into the making of a true collaborative competency. Continue Reading
The 2023 ASAP BioPharma Conference is coming to Boston next week, and among the many highlights will be a veritable parade of panel discussions. The leading lights and illustrious luminaries of alliances will help you navigate a constantly changing landscape of biopharma partnering. Continue Reading
Empathy and the patient journey have always been primary drivers for alliance managers in the biopharma industry. Doug Wenners will show ASAP BioPharma Conference attendees how to take their commitment one step further. Continue Reading
AstraZeneca's Community of Excellence gathers alliance management stakeholders across the organization to share best practices, trends, and ideas—and it costs nothing! This “simple, lean, and efficient” approach to COEs was featured at the 2022 ASAP BioPharma Conference. Continue Reading
In discovery-phase alliances, alliance managers need to have their eyes on the big picture and broader company strategy when working with scientists who are often too narrowly focused on short-term objectives. Three Takeda executives explained in an 2022 ASAP BioPharma Conference presentation. Continue Reading
Caroline Rader, Chris Black, Ken Marran, and Ryan Lenox brought ASAP BioPharma Conference took attendees behind the curtain of Merck's Big-Pharma-to-Big-Pharma alliances, which are responsible for major multibillion-dollar, market-moving drug candidates. Continue Reading
Jim Mullen of Editas Medicine delivered tips on dealing with “the Bermuda Triangle of contract issues”—decision rights, dispute resolution, and termination—in his ASAP BioPharma Conference keynote. When conflict arises, get agreement on the facts, but don't require a consensus decision. Continue Reading
What do biopharma alliance managers need to know about digital transformation? Microsoft's Elena Bonfiglioli outlined three things in her ASAP BioPharma Conference keynote: 1) culture that promotes privacy, 2) competencies, and 3) trust. Continue Reading
